Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Recombinant
- (285)
- (11)
- (65,867)
- (1)
For Use With (Application)
- (2)
- (970)
- (1)
- (23,540)
- (5)
- (1)
- (1)
- (67)
- (216)
- (4,420)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,448)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (157)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (253)
- (22,591)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,799)
- (253)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (105)
- (1)
- (3,750)
- (1,407)
- (3)
- (4)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (10)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,522)
- (2)
- (1)
- (160)
- (18)
- (48)
- (3)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (208)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,708)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,758)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (27,095)
- (235)
- (1)
- (3)
Species
- (2)
- (1)
- (2)
- (1)
- (89)
- (559)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,303)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (29,092)
- (5)
- (22)
- (8)
- (4)
- (1,291)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (8)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (233)
- (9)
- (2)
- (5)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,574)
- (1)
- (48)
Form
- (15)
- (1)
- (2)
- (45,208)
- (5,648)
- (245)
- (168)
- (56)
- (3,361)
Conjugate
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (59)
- (1)
- (2)
- (3)
- (1)
- (391)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (3)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (43,090)
- (1)
- (11)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
7,456
–
7,470
of
119,634
results
| Form | Powder |
|---|---|
| Color | White |
| Synonym | Sodium Caseinate |
MilliporeSigma™ Chemicon™ Recombinant Human Pigment Epithelium Derived Factor Protein
a 50 kDa secreted protein in conditioned medium from cultured fetal human retinal pigment epithelium (RPE) cells
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Formulation | 20 mM tris HCl with 50% glycerol and no preservative; pH 8 |
| Sequence | Amino acids Met1- Ala133 containing an N-terminal His-tag |
| For Use With (Application) | Control,Western Blot |
| Source | E. coli |
| Name | Human FABP3 (H-FABP) (Muscle and Heart) |
| Recombinant | Recombinant |
Invitrogen™ Human IL-10 Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Purity or Quality Grade | >95% by SDS-PAGE and HPLC analyses |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 18.6 kDa |
| Common Name | IL-10 |
| Gene Symbol | IL10 |
| Storage Requirements | -20°C |
| Expression System | E. coli |
| For Use With (Application) | Neutralization |
| Name | Human IL-10 |
| Accession Number | P22301 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | CSIF; cytokine; Cytokine synthesis inhibitory factor; GVHDS; H-IL-10; il 10; IL10; IL-10; IL-10 precursor; IL10A; IL10X; ILN; Interleukin; interleukin 10; Interleukin10; interleukin-10; MGC126450; MGC126451; RP11-262N9.1; T-cell growth inhibitory factor; TGIF |
| Product Type | Protein |
| Gene ID (Entrez) | 3586 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
MilliporeSigma™ Calbiochem™ Albumin, Human Serum, Fraction V
Prepared under non-denaturing conditions by modification of Cohn procedure
| Purity or Quality Grade | ≥95% by SDS PAGE |
|---|---|
| Form | Solid |
| Storage Requirements | 2° to 8°C |
| Source | Prepared from serum that has been shown by certified tests to be negative for HBsAg and for antibodies to HIV and HCV |
Gibco™ Human NT-4 Recombinant Protein
Recombinant Protein
Encompass Procurement Services
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
Non-distribution item offered as a customer accommodation; additional freight charges may apply.
Learn More
| Purity or Quality Grade | ≥98% by SDS-PAGE and HPLC |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 27.2 kDa |
| Common Name | NTF4 |
| Gene Symbol | NTF4 |
| Activity | ED50 = 20 - 50 ng/mL; determined by the dose-dependent induction of choline acetyl transferase activity in rat basal forebrain septal cultures. |
| Endotoxin Concentration | <0.1 ng/μg |
| Storage Requirements | -20°C |
| Sequence | Human NT-4 recombinant protein is a homodimer containing two 130 amino acid subunits |
| Expression System | E. coli |
| For Use With (Application) | Bioactivity |
| Name | Human NT-4 |
| Accession Number | P34130 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | 2900040K06Rik; AI462899; GLC10; GLC1O; neurotrophic factor 4; neurotrophic factor 5; neurotrophin 4; Neurotrophin 4/5; neurotrophin 5; Neurotrophin 5 (neurotrophin 4/5); neurotrophin 5 (neurotrophin 4/5); neurotrophin-4; Neurotrophin-5; neutrophic factor 4; Neutrophic factor 5; NT4; NT-4; NT4/5; NT-4/5; NT4/NT5; NT4P; NT5; NT-5; Ntf4; Ntf5; Ntf-5 |
| Product Type | Protein |
| Gene ID (Entrez) | 4909 |
| Formulation | Protein with no preservative |
| Recombinant | Recombinant |
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Molecular Weight (g/mol) | 44.26 kDa |
| Formulation | 20 mM tris HCl with 50% glycerol and no preservative; pH 8 |
| Sequence | Amino acids Met1- Leu355 containing an N-terminal His-tag |
| Concentration | 0.69 mg/mL |
| For Use With (Application) | Control,Western Blot |
| Source | E. Coli |
| Name | Human PON1 |
| Recombinant | Recombinant |
| Regulatory Status | RUO |
|---|---|
| Purification Method | Complete activation from homogeneous prothrombin by SDS-PAGE |
| Preparation Method | Aqueous Buffers or H2O (1mg/mL) |
| Form | Lyophilized |
| Formulation | Lyophilized from 200mM NaCl, 50mM citrate buffer, 0.1% PEG-8000, pH 6.5. Contains BSA as a stabilizer. |
| Immunogen | Thrombin |
| Storage Requirements | Following reconstitution, aliquot and freeze (−70°C). Stock solutions are stable for up to 2 months at −70°C. |
| Species | Human |
| Recombinant | Native |